Search    
         
Funding Registry

Welcome to the ACCP PBRN Funding registry. In order to aid clinicians and researchers alike in their pursuit of industry funding, this registry contains searchable information of the top 50 pharmaceutical companies offering funding opportunities. Users may search by priority area and/or company to pinpoint the best source of funding for their projects. If you have any questions or if the tool is not working for you, please contact PBRN staff at pbrn@accp.com.

To use this registry, first choose if you would like to search by priority area or company. If you search by priority area first, companies will appear in alphabetical order. If you would like to have more information about the company, simply click the “plus sign” next to the company name. Information about that company’s preferred submission method (RFP or IIS), list of priority areas, etc. will appear. If you would like to search by company, simply type the name of the company and the information will appear once “search” is selected.

Click here for definitions.

Filter information below by

Sponsor through RFP :No
RFP Website :
IIS Funding :Yes
Priority Areas :Yes
Priorities Posted Online :Yes
Priority Areas Listed :Branded Generic Pharmaceuticals,
Diagnostics,
Mature Pharmaceutical Products,
Pediatric Nutrition,
Vascular Devices,
Priority Areas Website :Click Here
Submission Method Description :To receive materials to submit a research proposal, please e-mail a brief description of the study and support being requested, which may include product, financial, and/or technical support to: adc_iis@abbott.com with attention to: Chair, Scientific Research Review Committee
Designated Contact :Yes
Contact Info :adc_iis@abbott.com with attention to: Chair, Scientific Research Review Committee
Submission Form :
Additional Info :
Sponsor through RFP :No
RFP Website :
IIS Funding :Yes
Priority Areas :Yes
Priorities Posted Online :Yes
Priority Areas Listed :Hepatology,
Immunology,
Neuroscience,
Oncology,
Pancreatology,
Renal,
Women's Health,
Priority Areas Website :Click Here
Submission Method Description :Investigators wishing to submit a proposal for an investigator-initiated study that align with AbbVie's IIS Priorities should do so via the IIS portal: https://abbvie.envisionpharma.com/vt_abbvie/
Designated Contact :No
Contact Info :
Submission Form :
Additional Info :Abbvie also has an Open Innovation Program through which investigators can obtain potent, selective, well-characterized tool compounds or probes to conduct preclinical research. (http://www.openinnovation.abbvie.com/)
Sponsor through RFP :No
RFP Website :
IIS Funding :Yes
Priority Areas :Yes
Priorities Posted Online :Yes
Priority Areas Listed :
Priority Areas Website :
Submission Method Description :Information about research grants here: http://www.abiomed.us/medical-professionals/research-grants/ Grant requests can be made here: http://www.abiomed.us/medical-professionals/research-grant-request/ Scientific or clinical proposals related to Abiomed Products or disease state areas where Abiomed has an interest in supporting important research
Designated Contact :No
Contact Info :
Submission Form :
Additional Info :Current products: Impella percutaneous ventricular assist device. Current disease states of interest: high-risk percutaneous coronary intervention, advanced heart failure, cardiogenic shock
Sponsor through RFP :No
RFP Website :
IIS Funding :Yes
Priority Areas :Yes
Priorities Posted Online :Yes
Priority Areas Listed :Complement-Mediated Diseases focusing on Paroxysmal Nocturnal Hemoglobinuria and Atypical Hemolytic Uremic SyndromeMetabolic ,
Immuno-oncology,
Neurology Diseases,
Priority Areas Website :Click Here
Submission Method Description :Investigators interested in submitting a concept proposal to Alexion for consideration will first have to register on the web-based system with their profile. Once you have registered in the system, you can submit a concept proposal electronically. Email submissions are not accepted. To complete the submission of your concept proposal, please specify the type of support you are requesting (funding, drug product or other), and include the following information: Study Title Contact Information Therapeutic Area Indication Study Duration Rationale Objectives Endpoints Curriculum Vitae Alexion will review each ISR proposal to confirm patient safety, scientific merit, operational feasibility, strategic alignment and portfolio and budget fit. This is a multistep review cycle, which takes about 3 months for a decision. After the first step of the review cycle, you will be asked for more detailed information, leading from a concept to a full pro
Designated Contact :Yes
Contact Info :https://alexion.envisionpharma.com/vt_alexion/
Submission Form :
Additional Info :Researchers looking to collaborate and create a partnership with Alexion can visit http://www.alexion.com/Research-Development/Discovery-Partnerships and become a Discovery Partner. Proposals can be submitted (https://alexion.envisionpharma.com/vt_alexion/) after aquiring a user ID and password
Sponsor through RFP :No
RFP Website :
IIS Funding :Yes
Priority Areas :Yes
Priorities Posted Online :Yes
Priority Areas Listed :Anti-Infectives,
Central Nervous System,
Eye Care,
Gastroenterology,
Medical Aesthetics & Dermatology,
Urology,
Women's Health,
Priority Areas Website :Click Here
Submission Method Description :You will be required to establish a user account prior to submission. Upon successful registration, you will be issued a username and password. Once your registration is approved, you will be eligible to submit a proposal. The specific criteria and requirements for proposals can be found under the Clinical and Non-clinical sections on the Portal. Only fully completed online proposals will be considered for review.
Designated Contact :Yes
Contact Info :https://iit.frxis.com/home/LandingPage.aspx?ReturnUrl=%2fhome%2f
Submission Form :
Additional Info :
Sponsor through RFP :No
RFP Website :
IIS Funding :Yes
Priority Areas :Yes
Priorities Posted Online :No
Priority Areas Listed :Bone,
Cardiology,
Inflammation,
Nephrology,
Neurosciences,
Priority Areas Website :
Submission Method Description :Website: amgeniss.com. Medical liaisons can provide areas of interest.
Designated Contact :Yes
Contact Info :Website: AmgenIss.com
Submission Form :
Additional Info :
Sponsor through RFP :No
RFP Website :
IIS Funding :Yes
Priority Areas :Yes
Priorities Posted Online :No
Priority Areas Listed :Apixaban,
Priority Areas Website :
Submission Method Description :http://www.arista-usa.com/ https://www.bms.com/clinical_trials/investigator_sponsored_research/Pages/default.aspx
Designated Contact :No
Contact Info :
Submission Form :
Additional Info :ARISTA Program - program that is open for proposals once each year that accepts proposals for research on apixaban. Priority is on obtaining data in populations with unmet needs. Not focused on expanding indications or new doses. ISR Program - open year round for ISR proposals. Not specific to apixaban.
Sponsor through RFP :No
RFP Website :
IIS Funding :No
Priority Areas :No
Priorities Posted Online :No
Priority Areas Listed :
Priority Areas Website :
Submission Method Description :
Designated Contact :No
Contact Info :
Submission Form :
Additional Info :Based on the information on the website it does not appear that Aspen offers and RFP or IIT mechanism.
Sponsor through RFP :Yes
RFP Website :Click Here
IIS Funding :Yes
Priority Areas :No
Priorities Posted Online :No
Priority Areas Listed :
Priority Areas Website :
Submission Method Description :All concepts can be submitted at: www.astellasinvestigatorsponsoredresearch.com. This is an online portal for all things ISR related - submission/monitoring, etc.
Designated Contact :No
Contact Info :
Submission Form :
Additional Info :The initial concept submission for an ISR should NOT be a detailed, time-consuming submission. In essence, it is meant to be a simple submission of an idea to determine initial interest within Astellas. This prevents the investigator from spending an inordinate amount of time in submitting an initial concept simply to have it rejected. If the concept is determined to be of interest to Astellas, the next phase would be submission of a full-blown, detailed protocol. Please refer to the ISR site re
Sponsor through RFP :No
RFP Website :
IIS Funding :Yes
Priority Areas :Yes
Priorities Posted Online :Yes
Priority Areas Listed :
Priority Areas Website :Click Here
Submission Method Description :The Primary Researcher must first submit a study proposal. Study proposals are reviewed each month by review and evaluation teams, which included members from the Company Medical, Biostatistics, and Regulatory local and global review and evaluation teams. Once a proposal is reviewed and if approved, the researcher will be invited to submit a full protocol for review. You must login and have a username in order to view priority areas https://az.envisionpharma.com/vt_az_medi/
Designated Contact :No
Contact Info :
Submission Form :
Additional Info :
Sponsor through RFP :No
RFP Website :
IIS Funding :Yes
Priority Areas :Yes
Priorities Posted Online :Yes
Priority Areas Listed :Hematology,
Immunology,
Oncology,
Priority Areas Website :Click Here
Submission Method Description :Baxalta is now part of Shire labs so the process for acquiring the information is done through the Shire labs program. Visit www.ShireSupport.com for more information on submitting an application.
Designated Contact :Yes
Contact Info :Seems to be a portal
Submission Form :
Additional Info :
Sponsor through RFP :No
RFP Website :
IIS Funding :No
Priority Areas :No
Priorities Posted Online :No
Priority Areas Listed :
Priority Areas Website :
Submission Method Description :
Designated Contact :No
Contact Info :
Submission Form :
Additional Info :Based on the information on the US Bayer site, I cannot determine that they offer an RFP or IIT mechanism
Sponsor through RFP :No
RFP Website :
IIS Funding :Yes
Priority Areas :Yes
Priorities Posted Online :Yes
Priority Areas Listed :
Priority Areas Website :Click Here
Submission Method Description :Online https://biogen.envisionpharma.com/vt_biogen/. To view priority areas and the full submission process, you must create an account and register.
Designated Contact :No
Contact Info :
Submission Form :
Additional Info :Rolling process all done online https://biogen.envisionpharma.com/vt_biogen/
Sponsor through RFP :No
RFP Website :
IIS Funding :Yes
Priority Areas :Yes
Priorities Posted Online :Yes
Priority Areas Listed :Diabetes,
Priority Areas Website :Click Here
Submission Method Description :You must fill out one of the templates provided at https://www.boehringer-ingelheim.com/value-through-innovation/clinical-trial/diabetes/iis_diabetes. Once the template is completed, send the form to info.iis-diabetes@boehringer-ingelheim.com.
Designated Contact :Yes
Contact Info :info.iis-diabetes@boehringer-ingelheim.com
Submission Form :In CAP folder
Additional Info :
Sponsor through RFP :No
RFP Website :
IIS Funding :Yes
Priority Areas :Yes
Priorities Posted Online :Yes
Priority Areas Listed :Cardiovascular,
Immunology,
Oncology,
Virology,
Priority Areas Website :Click Here
Submission Method Description :there is a competitive investigator initiated proposal process called ARISTA. This grant period is open once a year for a specified time and grants are awarded after an independent committee reviews them. Priority is on obtaining data in populations with unmet needs. Not focused on expanding indications or new doses. http://www.arista-usa.com/ http://bms.com/clinical_trials/investigator_sponsored_research/us_clinical_research_investigators/Pages/default.aspx http://www.bms.com/responsibility/grantsandgiving/Pages/default.aspx
Designated Contact :No
Contact Info :
Submission Form :
Additional Info :The local Medical Science Liaison for the therapeutic area is a good resource to inform you about this changing landscape. Calling BMS Medical Information can connect you with that individual.
Sponsor through RFP :No
RFP Website :
IIS Funding :Yes
Priority Areas :Yes
Priorities Posted Online :Yes
Priority Areas Listed :Hematology,
Immunology,
Inflammation,
Oncology,
Priority Areas Website :Click Here
Submission Method Description :Please submit your request directly through https://celgenemedicalaffairs.force.com/Investigators/login. You will be required to establish a user account prior to submission.
Designated Contact :No
Contact Info :
Submission Form :
Additional Info :Here is the website to log into to start the process and access the forms; https://celgenemedicalaffairs.force.com/Investigators/login Hematology and Oncology for the Americas only. Inflammation and immunology research in all other countries
Sponsor through RFP :No
RFP Website :
IIS Funding :Yes
Priority Areas :Yes
Priorities Posted Online :Yes
Priority Areas Listed :Acquired Bleeding,
Coagulation,
Hereditary Angioedema,
Immunoglobulins,
Oral Anticoagulants,
Priority Areas Website :Click Here
Submission Method Description :1. Contact your regional Medical Science Liaison (https://www.cslbehringrequests.com/iis/request/iis-request.aspx) to review the study concept and ensure all requirements are met. 2. Complete the IIS Concept Submission form available for download. 3. Attach your signed and dated CV or Resume as well as an estimated budget. 4. Submit the concept application with attachments to your regional Medical Science Liaison. 5. The CSL Behring Medical Affairs department will review the concept. 6. If the concept is accepted, your Medical Science Liaison will guide you through the process of making a full submission and provide you with the necessary information.
Designated Contact :Yes
Contact Info :Contact your regional Medical Science Liaison (https://www.cslbehringrequests.com/iis/request/iis-request.aspx)
Submission Form :CAP Folder
Additional Info :
Sponsor through RFP :No
RFP Website :
IIS Funding :Yes
Priority Areas :Yes
Priorities Posted Online :Yes
Priority Areas Listed :Cell Therapy,
End-organ Diseases,
Oncology,
Pain/Sensory Neuron,
Rare Diseases, Anaemia, Gut Microbiome-Related Diseases,
Technology,
Priority Areas Website :Click Here
Submission Method Description :The following minimum information must be submitted to Daiichi Sankyo at IIS@dsi.com in order to conduct a review of an unsolicited IIS proposal: Principal Investigator, institution name, type of study (clinical, non-clinical), type of request (drug product, financial, or both), budget and drug product request details, study rationale, study design (e.g. control, number of treatment arms, product doses, treatment duration, numbers of animals), primary objective(s), planned timelines. Additional information requirements for clinical IIS proposals: inclusion/exclusion criteria, study population/indication, study endpoints, planned sample size and statistical powering justification, planned number of subjects and sites/site locations (country only), study visit schedule of events. To request a template to assist you, or if you prefer to submit a full application, contact IIS@dsi.com.
Designated Contact :Yes
Contact Info :IIS@dsi.com
Submission Form :
Additional Info :
Sponsor through RFP :No
RFP Website :
IIS Funding :Yes
Priority Areas :Yes
Priorities Posted Online :Yes
Priority Areas Listed :Central Nervous System,
Metabolism,
Oncology,
Priority Areas Website :Click Here
Submission Method Description :All IIS applications are processed as follows: 1. Applicant reviews the entire content of the eisaigrants.com IIS website. 2. Applicant selects the product or investigational compound that will be the subject of the IIS research. 3. Applicant completes the Eisai Investigator Initiated Studies (IIS) Application and submits to the IIS Coordinator 4. IIS Coordinator ensures that the Applicant has correctly completed all components of the application and then forwards the Request to the applicable product or investigational compound IIS Committee for review and approval 5. IIS Coordinator notifies Applicant whether grant has been approved or denied. Approval is on a conditional basis, subject to the execution of an Agreement, in a form acceptable to Eisai. 6. If application is approved, the IIS Coordinator oversees the process of generating a written agreement between Eisai and the applicable requesting organization. 7. Upon contract execution, IIS Coordinator arranges for issuance
Designated Contact :Yes
Contact Info :Send all documentation to: email: Eisai_iisgrants@eisai.com or Mail: Eisai Inc. Investigator Initiated Studies (IIS) Program Medical Affairs Department 100 Tice Boulevard Woodcliff Lake, NJ 07677 USA
Submission Form :
Additional Info :
Sponsor through RFP :No
RFP Website :
IIS Funding :Yes
Priority Areas :Yes
Priorities Posted Online :Yes
Priority Areas Listed :Animal Health,
Biotechnology Discovery and Research,
Chorus,
Diabetes,
Drug Delivery and Devices,
Emerging Markets,
Immunology,
Neuroscience,
Oncology,
Priority Areas Website :Click Here
Submission Method Description :​The sponsor-investigator designs the proposal and/or protocol for the IIT or ExIST program and submits the request to Lilly. The initial submission includes the application and proposal. A sponsor-investigator curriculum vitae (CV) and draft budget are also submitted as required attachments to the application. Submission of a full protocol and detailed budget is not required until after preliminary support for continued review is received. However, sponsor-investigators are not prohibited from initially submitting a fully developed protocol and detailed budget with the IIT application and sponsor-investigator CV. Proposals must clearly describe the objectives and scientific importance of the proposed research. The Committee expects concise, focused proposals that explicitly describe links and benefits of the proposed research. The proposal should include the following information: Rationale: Study rationale and how it relates to Lilly product. Previous work: Description of work/fi
Designated Contact :Yes
Contact Info :https://www.lillyinvestigatorresearch.com/requestForm
Submission Form :
Additional Info :
Sponsor through RFP :No
RFP Website :
IIS Funding :Yes
Priority Areas :Yes
Priorities Posted Online :Yes
Priority Areas Listed :
Priority Areas Website :Click Here
Submission Method Description :Submission site available upon registration at: https://fmcrtg-grants.com/
Designated Contact :Yes
Contact Info :Submission site available upon registration at: https://fmcrtg-grants.com/
Submission Form :
Additional Info :
Sponsor through RFP :No
RFP Website :
IIS Funding :Yes
Priority Areas :No
Priorities Posted Online :No
Priority Areas Listed :
Priority Areas Website :
Submission Method Description :An online application/submission process is required. http://www.gilead.com/research/investigator-sponsored
Designated Contact :Yes
Contact Info :Online application/submission is required. However, initial discussion with designated medical scientist may be beneficial.
Submission Form :
Additional Info :
Sponsor through RFP :Yes
RFP Website :Click Here
IIS Funding :Yes
Priority Areas :Yes
Priorities Posted Online :Yes
Priority Areas Listed :Autoimmune,
Diabetes,
Growth Hormone,
Oncology,
Priority Areas Website :Click Here
Submission Method Description :For more information about the ISR program, please contact Cynthia Henning at cynthia.henning@grifols.com.
Designated Contact :Yes
Contact Info :For more information about the ISR program, please contact Cynthia Henning at cynthia.henning@grifols.com.
Submission Form :
Additional Info :Investigator Sponsored Research proposals are evaluated on scientific merit, therapeutic research interests, and the qualifications of the applicant. Proposals are evaluated and funded on a semiannual basis.
Sponsor through RFP :Yes
RFP Website :Click Here
IIS Funding :Yes
Priority Areas :Yes
Priorities Posted Online :Yes
Priority Areas Listed :
Priority Areas Website :Click Here
Submission Method Description :Website for Investigator Sponsored Studies https://iss.gsk.com
Designated Contact :No
Contact Info :
Submission Form :No
Additional Info :ISS: GSK support of approved proposals can be in the form of funding and/or study materials (including GSK products, adjuvant for vaccines, placebo, or other medicinal products necessary for the research) In exceptional circumstances where the study requires a specialized capability to perform a specific activity (e.g. assays in the case of vaccines or biomarker research) that the sponsor does not have and cannot feasibly retain an appropriate vendor; GSK may perform the specific activity as
Sponsor through RFP :No
RFP Website :
IIS Funding :Yes
Priority Areas :Yes
Priorities Posted Online :Yes
Priority Areas Listed :Cardiovascular,
Immunology,
Infectious Diseases & Vaccines,
Metabolism,
Neuroscience,
Oncology,
Priority Areas Website :Click Here
Submission Method Description :There is a link on the company website
Designated Contact :No
Contact Info :
Submission Form :
Additional Info :Not at this time
Sponsor through RFP :No
RFP Website :
IIS Funding :Yes
Priority Areas :Yes
Priorities Posted Online :Yes
Priority Areas Listed :Cardiovascular,
Immunology,
Infectious Diseases & Vaccines,
Metabolism,
Neuroscience,
Oncology,
Priority Areas Website :Click Here
Submission Method Description :You can either request a visit from and MSL or you can submit online directly
Designated Contact :No
Contact Info :
Submission Form :
Additional Info :It is best to contact the company and find the MSL assigned to you to help complete the process
Sponsor through RFP :No
RFP Website :
IIS Funding :Yes
Priority Areas :Yes
Priorities Posted Online :Yes
Priority Areas Listed :Abuse, Misuse, Diversion and Overdose of Oral Opioid Analgesics,
Ankylosing Spondylitis,
Dermatomyositis/Polymyositis,
Drug Delivery and Devices,
Infantile Spasms,
Intravenous Acetaminophen,
Melanocortin Biology,
Multiple Sclerosis,
Nephrotic Syndrome,
Optic Neuritis,
Pain/Sensory Neuron,
Patient-Reported Outcomes,
Pharmacoeconomics,
Pharmacokinetics/Pharmacodynamics,
Psoriatic Arthritis,
Rheumatoid Arthritis,
Sarcoidosis,
Systemic Lupus Erythematosus,
Uveitis,
Priority Areas Website :Click Here
Submission Method Description :All applications are submitted through a portal (http://www.mallinckrodt.com/research/medical-affairs/investigator-initiated-research).
Designated Contact :No
Contact Info :
Submission Form :
Additional Info :
Sponsor through RFP :No
RFP Website :
IIS Funding :Yes
Priority Areas :Yes
Priorities Posted Online :Yes
Priority Areas Listed :Respiratory,
Priority Areas Website :Click Here
Submission Method Description :You may submit an online application at http://www.medapharma.us/iis/apply.php The following documents are required at time of application: A completed IIS Request Form A study protocol or proposal that includes, at a minimum, the study objectives, background and rationale, supporting literature, disease stage, clinical population description and size, and study plan Investigator CV Itemized budget [when funding is requested] Form W-9 Request for TIN [for US studies]
Designated Contact :Yes
Contact Info :For additional information, Contact MEDA's IIS Office at: InvestigatorInitiatedStudies@meda.us Meda Pharmaceuticals 265 Davidson Ave. Somerset, NJ 08873
Submission Form :
Additional Info :All submitted requests will undergo an internal review by Meda's IIS Review Committee consisting of company personnel from relevant disciplines. By accepting IIS requests, MEDA does not imply or guarantee that the IIS request will be approved. A decision is based on strategic fit with Meda's areas of interest, investigator research experience, scientific merit, adherence to Good Clinical Practice, etc. You will receive written notification of the IIS Committee's decision upon comp
Sponsor through RFP :No
RFP Website :
IIS Funding :Yes
Priority Areas :Yes
Priorities Posted Online :Yes
Priority Areas Listed :Cardiovascular,
Endocrinology,
Infectious Diseases,
MSD,
Neuroscience,
Oncology,
Surgery,
Vaccines,
Women's Health,
Priority Areas Website :Click Here
Submission Method Description :http://engagezone.msd.com/misp.html By therapeutic area the areas of interest are posted as well as the timelines for submission and review. All submissions are entered through an online portal (https://merck.envisionpharma.com/vt_merck/ ). You must create a user account for this portal. Only complete proposals are considered.
Designated Contact :No
Contact Info :
Submission Form :
Additional Info :Website has all required information, including area of interest for all therapeutic areas. Note for Hematology/Oncology, Infectious Diseases, and Cardio-metabolic (cardiology/diabetes) there are Regional Research Scientific Directors. Go to website, located the therapeutic area of interest and contact the person listed - they should be able to connect the interested researcher with the regional scientific director
Sponsor through RFP :No
RFP Website :
IIS Funding :Yes
Priority Areas :Yes
Priorities Posted Online :Yes
Priority Areas Listed :Cardiac Surgical Procedures,
Multiple Sclerosis,
Priority Areas Website :Click Here
Submission Method Description :Submissions are completed through an online grant portal.
Designated Contact :No
Contact Info :
Submission Form :
Additional Info :Contact Grantsadministrator@mylan.com for more information.
Sponsor through RFP :No
RFP Website :
IIS Funding :Yes
Priority Areas :Yes
Priorities Posted Online :No
Priority Areas Listed :Cardiovascular,
Immunology,
Neuroscience,
Oncology,
Respiratory,
Priority Areas Website :
Submission Method Description :Contact the perceptive Medical Science Liaison (MSL) for process, requirement, and priority disease areas for submission and review details.
Designated Contact :Yes
Contact Info :Perspective Medical Science Liaison (MSL), for example, contact Transplant MSL for research proposals related with transplantation research and product(s).
Submission Form :
Additional Info :
Sponsor through RFP :Yes
RFP Website :Click Here
IIS Funding :Yes
Priority Areas :Yes
Priorities Posted Online :Yes
Priority Areas Listed :Cardio-Renal,
Neuroscience,
Oncology,
Priority Areas Website :Click Here
Submission Method Description :Everything is on the website with requirements, submission process, etc.
Designated Contact :No
Contact Info :
Submission Form :All instructions are listed on the OAPI website
Additional Info :All online. MSLs can be contacted for more information.
Sponsor through RFP :Yes
RFP Website :Click Here
IIS Funding :Yes
Priority Areas :Yes
Priorities Posted Online :Yes
Priority Areas Listed :Inflammation & Immunology,
Metabolic Diseases & Cardiovascular Risk,
Neuroscience & Pain,
Oncology,
Rare Disease,
Vaccines,
Priority Areas Website :Click Here
Submission Method Description :IT depends. Look at the website.
Designated Contact :No
Contact Info :
Submission Form :
Additional Info :All of the proposals go through the website. However, the local Field Medical Directors in the US are aware of the priorities, strategic focus and the whole process and can provide guidance. There is also a 'concept' submission process for investigator research (vs submitting a whole proposal) as the investigator can gauge interest.
Sponsor through RFP :No
RFP Website :
IIS Funding :Yes
Priority Areas :Yes
Priorities Posted Online :Yes
Priority Areas Listed :Cardiovascular,
Immunology,
Infectious Diseases,
Inflammation,
Metabolism,
Oncology,
Ophthalmology,
Pain,
Rare Disease,
Priority Areas Website :Click Here
Submission Method Description :Use the Investigator-Initiated Studies (IIS) Web Portal. For concept and proposal submissions: http://iisgrants.regeneron.com/account/logon?ReturnUrl=%2f. For inquiries: grants@regeneron.com, areas of interest disclosed per discussion with regional science manager (RSM)
Designated Contact :No
Contact Info :
Submission Form :
Additional Info :
Sponsor through RFP :No
RFP Website :
IIS Funding :Yes
Priority Areas :Yes
Priorities Posted Online :Yes
Priority Areas Listed :Cardiovascular,
Hematology,
Hemophilia,
Immunology,
Infectious Diseases,
Metabolism,
Neuroscience,
Oncology,
Ophthalmology,
Personalised Healthcare,
Rare Disease,
Respiratory,
Priority Areas Website :Click Here
Submission Method Description :Researchers are invited to submit their concept proposal via the IIS submission portal. Concept submission will be reviewed collectively by the Roche Review Committee based on scientific merit and alignment with corporate research and development plans. The requester will be informed about the outcome and should Roche be interested in the concept submission, the investigator will be contacted and invited to submit further details and a final protocol on the IIS in order to be considered for full approval. https://roche.envisionpharma.com/vt_roche_genentech/
Designated Contact :Yes
Contact Info :http://www.roche.com/about/business/disease_areas.htm
Submission Form :
Additional Info :
Sponsor through RFP :No
RFP Website :
IIS Funding :Yes
Priority Areas :No
Priorities Posted Online :Yes
Priority Areas Listed :Animal Health,
Cardiovascular,
Degenerative Diseases of the Elderly,
Diabetes,
Immune-Mediated Diseases,
Infectious Diseases,
Multiple Sclerosis,
Oncology,
Ophthalmology,
Rare Disease,
Vaccines,
Priority Areas Website :Click Here
Submission Method Description :When submitting your proposal you will now encounter a high-level Summary of Concept review step. You will NOT be able to submit a full concept proposal until the Summary of Concept had been reviewed/approved. You will receive a notification from your Sanofi Genzyme contact once a full concept has been requested.
Designated Contact :Yes
Contact Info :http://en.sanofi.com/partners/being_our_partner/contacts/contacts.aspx
Submission Form :
Additional Info :Specific areas of interest for IIS proposals are available upon log-in to the Sanofi IIS submission site: https://sanofi.envisionpharma.com/vt_genzyme_sanofi/
Sponsor through RFP :Yes
RFP Website :Click Here
IIS Funding :Yes
Priority Areas :Yes
Priorities Posted Online :Yes
Priority Areas Listed :Genetic Diseases,
Hematology,
Immunology,
Internal Medicine,
Neuroscience,
Oncology,
Ophthalmics,
Priority Areas Website :Click Here
Submission Method Description :"Online submission site and 2017 IIR Program Cycle Times can be found at: https://ist.shiresupport.com/home/(S(wsl4prfpzvgxlm2skwy5ivx1))/Default.aspx?ReturnUrl=%2fhome General Shire research support site (which includes link to IST): http://www.shiresupport.com/ Link to IST Site (which includes 2017 Areas of Interest): https://ist.shiresupport.com/home/(S(3wolxhgvt2yzaqwkzfdmieqf))/Default.aspx?ReturnUrl=%2fhome"
Designated Contact :Yes
Contact Info :https://ist.shiresupport.com/home/(S(wsl4prfpzvgxlm2skwy5ivx1))/Default.aspx?ReturnUrl=%2fhome
Submission Form :
Additional Info :Although Shire may provide IIR grants in a variety of different therapeutic areas and disease states, Shire is more likely to support grants that focus on current Areas of Interest (AOI). Current areas of interest by therapeutic area questions of interest can be found at: https://ist.shiresupport.com/home/(S(wsl4prfpzvgxlm2skwy5ivx1))/Default.aspx?ReturnUrl=%2fhome Please feel free submit a letter of inquiry by email to (IIRsupport@Shire.com) before sending a proposal if your research reques
Sponsor through RFP :No
RFP Website :
IIS Funding :No
Priority Areas :No
Priorities Posted Online :No
Priority Areas Listed :
Priority Areas Website :
Submission Method Description :
Designated Contact :No
Contact Info :
Submission Form :
Additional Info :
Sponsor through RFP :No
RFP Website :
IIS Funding :Yes
Priority Areas :Yes
Priorities Posted Online :No
Priority Areas Listed :
Priority Areas Website :
Submission Method Description :IISR program supports studies addressing important medical & scientific questions related to our compounds & therapeutic areas of interest below (https://www.takeda.com/what-we-do/research-and-development/investigator-initiated-sponsored-research/): Therapeutic areas: CNS, gastroenterology, oncology, vaccines Products: alogliptin, azilsartan, bortezomib, brentuximab vedotin, colchicine, dexlansoprazole, febuxostat, ixazomib, lansoprazole, leuprorelin acetate, lubiprostone, pantoprazole, vedolizumab, vonoprazan, vortioxetine
Designated Contact :No
Contact Info :
Submission Form :Investigators wishing to submit a proposal for an
Additional Info :
Sponsor through RFP :No
RFP Website :
IIS Funding :No
Priority Areas :No
Priorities Posted Online :No
Priority Areas Listed :Central Nervous System,
Respiratory,
Priority Areas Website :
Submission Method Description :
Designated Contact :No
Contact Info :
Submission Form :
Additional Info :
Sponsor through RFP :Yes
RFP Website :Click Here
IIS Funding :Yes
Priority Areas :Yes
Priorities Posted Online :Yes
Priority Areas Listed :Ankylosing Spondylitis,
Axial Spondyloarthritis,
Chrohn's Disease,
Epilepsy,
Low Bone Mass Disorder,
Parkinson's Disease,
Psoriatic Arthritis,
Restless Legs Syndrome,
Priority Areas Website :Click Here
Submission Method Description :UCB is using the eRequest on-line submission portal to manage all Investigator-Initiated Study requests worldwide. To submit a concept, please click here: https://erequest.ucb.com/ If a concept is recommended for a full proposal submission, an IIS Team member will contact the applicant with instructions. Current timeline information can be found at: http://www.ucb.com/our-company/funding/usa
Designated Contact :Yes
Contact Info :https://erequest.ucb.com/
Submission Form :
Additional Info :
Sponsor through RFP :No
RFP Website :
IIS Funding :Yes
Priority Areas :Yes
Priorities Posted Online :No
Priority Areas Listed :
Priority Areas Website :
Submission Method Description :Interested providers should reach out to the MSL for their region to facilitate submission of IIS
Designated Contact :Yes
Contact Info :Inquiries may be directed to Daniel Stevens at drs@veloxis.com and will be forwarded to the appropriate individual.
Submission Form :
Additional Info :
Sponsor through RFP :No
RFP Website :
IIS Funding :Yes
Priority Areas :Yes
Priorities Posted Online :No
Priority Areas Listed :HIV Infection/Treatment,
Priority Areas Website :
Submission Method Description :Suggest interested people contact Belinda Ha or Gary Pakes and they can provide information and feedback.
Designated Contact :Yes
Contact Info :belinda.f.ha@viivhealthcare.com or gary.e.pakes@viivhealthcare.com
Submission Form :
Additional Info :Contact Belinda Ha or Gary Pakes for the latest information and procedures.